Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
The Laryngoscope|December 21, 2018
What makes us tick: Implications of personality differences among otolaryngology residents and facultyJennifer A Villwock, Sarah N Bowe, Duncan C Rotich, et al.
The Journal of Urology|August 12, 2005
Ventilatory and hemodynamic changes during retroperitoneal and transperitoneal laparoscopic nephrectomy: a prospective real-time comparisonAndrei Nadu, Perla Ekstein, Amir Szold, et al.
Research Square|July 3, 2026
Spatial Immune Model of Alveolar Lung Infection (SIMALI) Identifies Structural Determinants of Lung InflammationHumayra Tasnim, Stephanie Forrest, Steven Hofmeyr, et al.
Journal of Neuropathology and Experimental Neurology|January 20, 2009
Hyaline protoplasmic astrocytopathy of neocortexE Tessa Hedley-Whyte, James E Goldman, Maiken Nedergaard, et al.
RMD Open|March 5, 2022
Evaluation of response to 13-valent conjugated pneumococcal vaccination in patients with rheumatoid arthritis receiving upadacitinib: results from a phase 2 open-label extension studyKevin Winthrop, Juan Ignacio Vargas, Edit Drescher, et al.
JCI Insight|January 28, 2021
The Na+, K+-ATPase β1 subunit regulates epithelial tight junctions via MRCKαHaiqing Bai, Rui Zhou, Michael Barravecchia, et al.
Urology|October 2, 2007
Extending the application of tubeless percutaneous nephrolithotomyMario Sofer, Avi Beri, Alan Friedman, et al.
Arthritis Research & Therapy|December 4, 2019
Effects of upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugsVibeke Strand, Michael Schiff, Namita Tundia, et al.
Clinical Pharmacology and Therapeutics|January 20, 2023
Mitigating Drug-Target-Drug Complexes in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Switch C5 InhibitorsJun-Ichi Nishimura, Antoine Soubret, Noriko Arase, et al.
Arthritis Research & Therapy|December 10, 2019
Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXTVibeke Strand, Janet Pope, Namita Tundia, et al.
Pageof 8